References
- Brenner B, Avivi I, Lishner M. Haematological cancers in pregnancy. Lancet 2012;379:580–587.
- Kasenda B, Ruckert A, Farthmann J, et al. Management of multiple myeloma in pregnancy: strategies for a rare challenge. Clin Lymphoma Myeloma Leuk 2011;11:190–197.
- Pereg D, Koren G, Lishner M. The treatment of Hodgkin's and non-Hodgkin's lymphoma in pregnancy. Haematologica 2007;92: 1230–1237.
- Fonseca R, Hayman S. Waldenstrom macroglobulinaemia. Br J Haematol 2007;138:700–720.
- Groves FD, Travis LB, Devesa SS, et al. Waldenström's macroglobulinemia: incidence patterns in the United States, 1988-1994. Cancer 1998;82:1078–1081.
- Chapman A, Abraham W, Zamudio S, et al. Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int 1998;54:2056–2063.
- Pritchard JA. Changes in the blood volume during pregnancy and delivery. Anesthesiology 1965;26:393–399.
- Ramon Garcõa-Sanz SM, Torrequebrada A, Garcõa de Coca A, et al. Waldenstrom macroglobulinaemia: presenting features and outcome in a series with 217 cases. Br J Haematol 2001;115:572–582.
- Owen RG, Pratt G, Auer RL, et al. Guidelines on the diagnosis and management of Waldenstrom macroglobulinaemia. Br J Haematol 2014;165:316–333.
- Jolly EC, Hunt BJ, Ellis S, et al. “Benign” hypergammaglobulinemic purpura is not benign in pregnancy. Clin Rheumatol 2009;28(Suppl. 1):S11–S15.
- Schumacher A, Zenclussen AC. Regulatory T cells: regulators of life. Am J Reprod Immunol 2014;72:158–170.
- Lim HW, Hillsamer P, Banham AH, et al. Cutting edge: direct suppression of B cells by CD4 + CD25+ regulatory T cells. J Immunol 2005;175:4180–4183.
- Favaloro J, Brown R, Aklilu E, et al. Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state. Leuk Lymphoma 2014;55:1090–1098.
- Khot AS, Prince HM, Harrison SJ, et al. Myeloma and pregnancy: strange bedfellows? Leuk Lymphoma 2014;55:966–968.